Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Sepsis: Page 5
Immunexpress gets CE Mark for sepsis test
By
LabPulse.com staff writers
The test combines the company's SeptiCyte technology with Biocartis' Idylla platform and provides results in an hour. The reverse transcription polymerase chain reaction (RT-PCR) test is a gene expression assay that quantifies the relative expression levels of host response genes isolated from whole blood collected in the PAXgene blood RNA tube, according to the company.
March 26, 2020
Pathologists advance understanding of deadly female genital tract infections
By
Emily Hayes
Group A strep is typically found in the mouth, but it can also infect other mucosal areas of the body, with deadly results. The researchers noted that GAS surface proteins cause an estimated 700Â million human infections annually around the world, including 15Â million in the U.S. GAS is at the root of puerperal sepsis (also known as childbed fever), which is the leading cause of maternal deaths, and it causes necrotizing myometritis (inflammation of the uterine myometrium) as well as severe infections in newborns.
March 18, 2020
C-reactive protein test falls flat in newborns with suspected sepsis
By
Emily Hayes
The systematic review and meta-analysis evaluated the accuracy of CRP for determining the risk of late-onset infection in hospitalized neonatal patients, most of whom were preterm and had low birthweight. In the studies included in the analysis, CRP was compared with microbiological blood culture results as a reference standard.
February 11, 2020
Beckman Coulter floats Access PCT sepsis test in U.S.
By
LabPulse.com staff writers
The test measures the level of procalcitonin (PCT) in the blood as a means of determining the risk for sepsis, with results available in less than 20 minutes, according to the company. The assay can be used in core lab analyzers as part of routine workups for assessing sepsis risk, along with other methods for analysis. It was designed for use with a range of Beckman Coulter immunoassay systems, including Access 2, UniCel DxI 600, and UniCel DxI 800, the company noted in a statement.
January 27, 2020
Nanomix mobile, 3-in-1 sepsis test gets CE Mark
By
LabPulse.com staff writers
Designed for use with the company's handheld eLab analyzer either on the go or in laboratories, the S1 panel detects and quantifies three analytes at the same time in plasma specimens: lactate, procalcitonin, and C-reactive protein.
December 4, 2019
Blood test for predicting sepsis death in kids steps closer to reality
By
Emily Hayes
The test -- dubbed the Pediatric Sepsis Biomarker Risk Model (PERSEVERE) -- was developed and patented by researchers at Cincinnati Children's Hospital Medical Center toward the goal of preventing life-threatening septic shock, which is particularly risky for fragile children in critical care settings.
November 13, 2019
MicroRNAs predict problems in pneumonia patients
By
LabPulse.com staff writers
Identifying particular microRNAs -- small molecules involved in the regulation of gene expression -- using polymerase chain reaction (PCR) testing at the time patients are hospitalized with severe pneumonia could alert health professionals to risks and help prevent complications, reported Dr. Francisco Sanz, a pulmonologist at Consorci Hospital General Universitari de València, and colleagues. Testing is affordable, is readily available in hospitals, and takes from one to three hours, the researchers noted.
October 2, 2019
Surprise billing bills in limbo | USPSTF tempers urine test guidance | Blood cultures come first in sepsis
By
Emily Hayes
Dear LabPulse Member,
September 23, 2019
Why blood cultures must come first in suspected sepsis
By
Emily Hayes
The single-group study known as FABLED focused on 325 people with severe symptoms suggesting sepsis who were seen in North American emergency departments. Researchers found a big difference between results from an initial culture taken prior to antimicrobial therapy and a second culture taken soon after treatment, i.e., between 30 and 120 minutes afterward. The median time to a second culture was 70 minutes.
September 18, 2019
T2 Biosystems wins Medicare payment approval
By
LabPulse.com staff writers
As of October 1, 2019, U.S. hospitals treating Medicare inpatients with sepsis will now be eligible for a maximum NTAP amount of $97.50 -- 65% of the list price for one test -- for the T2Bacteria panel in addition to the appropriate sepsis diagnosis-related group (MS-DRG) reimbursement that hospitals receive under the Medicare hospital inpatient prospective payment system (IPPS), according to T2. The T2Bacteria panel is designed to detect sepsis-causing bacterial pathogens in the bloodstream in three to five hours without a blood culture.
August 6, 2019
AACC: Inflammatix sepsis test wins Disruptive Technology contest
By
Brian Casey
In the second annual edition of the competition, the company's HostDx Sepsis test for detecting sepsis won the majority of votes from an expert panel of five judges, as well as the audience participation vote. Inflammatix CEO Dr. Tim Sweeney, PhD, accepted a $5,000 prize on behalf of the Burlingame company for winning the award.
August 5, 2019
T2 stretches out globally with sepsis assays
By
LabPulse.com staff writers
Both panel tests are cleared by the U.S. Food and Drug Administration, are used with the company's T2Dx miniaturized magnetic resonance instrument, and provide results from whole blood within three to five hours, according to the company.
July 29, 2019
Previous Page
Page 5 of 6
Next Page